injections with lipidic-formulated synthetic miR-137. Moreover, immuno-blotting and -staining analysis of tumor tissue demonstrated that MCL-1was decreased in miR-137 overexpressing tumors compared to vector or delivery regent controls, as well as reduced Ki67 and increased Tunnel activities. Conclusions: Our fi ndings provide a proof-of-principle that lentivirus-based miR-137 or formulated synthetic miR-137 exerts therapeutic activity in preclinical models and support a framework for development of miR-137based treatment strategies in MM patients. Background: Molecular/genetic testing has become a daily routine for pathology. Examples include PCR or FISH based analyses for ERBB2, BRAF, KRAS, EGFR, ALK and KIT. Results from the tests permit genomic classifi cation of solid tumors and determine further managements. However, the current routine aims only to the most common tumor types based on prior translational studies. Large-scale cancer genomic data are gradually accumulated and are now available to research communities. Information from the large-scale well-maintained datasets may change our original concepts on cancer biology and genomics. Design: TCGA cBioPortal for Cancer Genomics was used as an initial source of data mining. Tumors with genetic alterations of a specifi c gene in greater than 10% cases were recorded, arbitrarily designated as high-frequency alteration. COSMIC database was then queried if known activating mutation could be identifi ed on the tumor. Results: High-frequency genetic alteration on ERBB2 was demonstrated in four different carcinomas including breast and gastric carcinoma. Various tumors were shown to have high-frequency alteration on BRAF, KRAS and EGFR. ALK gene was altered in 10% cutaneous melanomas in addition 11.6% lung adenocarcinomas. Only one non-GIST tumor, glioblastoma, showed high-frequency KIT alteration while the majority were amplifi cation. Below table shows examples.
Examples of Genetic Alterations in Solid Tumors
Conclusions: It is reasonable to extend PCR or FISH based analyses on all latestage tumors with high-frequency of specifi c genetic alterations. At least, available immunohistochemistry should be performed to select candidates for further target genetic testing. By doing so, more cancer patients may access to personalized management before next-generation sequencing is adopted as a clinical routine. Background: Spindle cell lesions in children can be diffi cult to characterize by fi ne needle aspiration (FNA) given that the differential diagnosis varies by age, and includes reactive tumor-like lesions as well as benign and malignant neoplasms. The objective of this study is to assess the diagnostic utility of FNA in the diagnosis of spindle cell lesions in the pediatric population. Design: Spindle cell lesions in patients 22 years of age or less were identifi ed during the time period from 2006 to 2012. Cytology cases and surgical cases with a prior FNA were included. Patient demographics, FNA diagnosis, ancillary studies and available follow-up were investigated and correlated. Results: A total of 18 cases were identifi ed in patients ranging from 7 weeks to 22 years of age, including 9 males and 9 females. Lesions included 14 (78%) soft tissue and 4 (22%) bone lesions. Samples were acquired by image-guided FNA (9; 50%) or palpation guided FNA (9; 50%). Thirteen (72%) cases had corresponding histopathology. Four (22%) cases had suffi cient material for ancillary studies. Table 1 shows the correlation of cytology adequacy and diagnoses with histological follow-up. No false positive diagnoses were identifi ed. 
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Conclusions:
In conclusion, FNA is useful to triage pediatric spindle cell lesions, in that it can usually exclude more common lymphoid lesions and small round blue cell tumors, thereby directing further management. However, obtaining suffi cient material for full characterization with ancillary studies can be diffi cult, and thus, maximizing cell block material or using concurrent core biopsy can be helpful. Neoplasms that are particularly diffi cult to diagnose on FNA due to low cellularity were hemangioma and osteosarcoma. Background: Intermediate and malignant fi broblastic-myofi broblastic tumors are an important group of malignancies that includes variants of fi brosarcoma, such as congenital infantile fi brosarcoma (CIFS), primitive myxoid mesenchymal tumor of infancy (PMMTI), and undifferentiated sarcoma (US). To date, little is known about the involvement of microRNAs in these tumors. MiR-125b regulates cellular quiescence (reversible cell-cycle arrest) and has been reported to be up-regulated in quiescent fi broblasts. However, the down-regulation of miR-125 has been reported in several tumors where it exhibits tumor suppressor properties, while its over-expression in other malignancies has been related to oncogene functions. Design: MiR-125b expression was analysed by using qRT-PCR in formalin-fi xed paraffi n-embedded specimens of 6 CIFSs with known ETV6-NTRK3 gene fusion, 6 sarcomas without this genetic alteration (3 PMMTIs and 3 USs), and 7 cutaneous scars (negative controls). Statistical analysis was done using Student t-test.
Results: qRT-PCR analysis highlighted that miR-125b was more expressed (p=0.0154) in the group of PMMTIs and USs than in cutaneous scars and showed an upward trend (p=0.0859) in these tumors in comparison with CIFSs. The amounts of this miRNA were similar (p=0.3027) in CIFSs and negative controls. Conclusions: Pediatric sarcomas lacking the ETV6-NTRK3 gene fusion show a signifi cantly higher expression of miR-125b compared to controls. Moreover, the upward trend of expression in PMMTI in comparison with CIFS supports their distinction. Whether the expression of miR-125b is related to the maintenance of a "primitive" status of the neoplastic cells or to its oncogenic properties should be investigated in further studies. Background: Neuroblastomas (NBs) are one of the most common solid tumors in infancy and early childhood. Exploring novel molecular biomarkers is a prerequisite for better risk stratifi cation and prediction of treatment response. The UBE4B gene encodes an E3/E4 ubiquitin ligase involved in the degradation of growth factor receptors (GFRs) and is located in the 1p36 region. 1p36 microdeletion and reduced UBE4B gene expression have been associated with poor outcome in NB patients, suggesting that UBE4B-mediated GFR degradation may be critical for neuroblastoma pathogenesis. Previous studies were based on mRNA and Western blotting analysis of frozen tissue specimens, and without addressing potential tumor heterogeneity, often a striking feature of NB. In this study, we evaluated UBE4B expression by immunohistochemistry (IHC) using formalin-fi xed paraffi n embedded (FFPE) tissue NB specimens, and correlated these fi nding with other genetic markers including MYCN gene amplifi cation, and 1p36 microdeletion by fl uorescence in situ hybridization (FISH). Design: We reviewed 35 archival NB cases diagnosed at our institution. FFPE specimens were used for IHC and FISH. The anti-UBE4B antibodies were purchased from Abcam. A commercially available FISH probe was used for 1p36 microdeletion (Vysis 1p36 Microdeletion region probe, Abbott Molecular). MYCN gene amplifi cations were analyzed on these cases using our clinically validated FISH assays. Results: Of the 35 NB cases, 21 cases were poorly or undifferentiated (PD/UF) and 8 cases differentiating. Among the PD/UF cases, tissue from 3 cases was from metastases to liver or bone marrow. UBE4B expression was diffusely or focally reduced in 18 cases (16 cases diffuse, 1 case focal and 1 case in PD component of intermixed type) (51.4%). Reduction of UBE4B expression was only seen in PD/UF NBs or the PD component of intermixed NBs. 4 of these cases demonstrated MYCN gene amplifi cation (22.2%).
Of Background: Acute Histologic Chorioamnionitis (HC) due to its known association with poor maternal and perinatal outcome is one of the most important fi ndings in placental pathology. The clinical signifi cance of HC in full term infants, however, remains controversial with respect to treatment and follow up. Recent literature suggests poor diagnostic utility of HC at term and a non-infectious etiology. In this study, we investigate the association and predictive ability of HC, funisitis, and Chorionic Plate Vasculitis (CPV) in diagnosing early onset sepsis in full term infants. Design: This was a retrospective study of symptomatic full term infants with presumed sepsis admitted to NICU from 2008-2011(n= 221). Laboratory markers for sepsis (CRP > 10, immature to total neutrophil (IT) ratio > 0.20), duration of antibiotic treatment (> 7 days), and blood culture results were obtained to confi rm clinical sepsis. Placenta histologic fi ndings of HC, funisitis, and CPV were reviewed and staged according to the Redline classifi cation system. Results: HC was present in all 221 patients, of which 96 (43%) were septic and 125 (56%) were non-septic. There was a signifi cant trend between increasing stages of HC and sepsis (P = 0.005). Funisitis was present in 60 (63%) of septic patients and 65 (52%) of non-septic patients. There was no trend between increasing stages of funisitis (stages 1 and 2) and sepsis. One case with funisitis stage 3 was excluded from analysis. CPV was present in 66 (69%) of septic patients and 66 (53%) of non-septic patients (P = 0.01).
The presence of HC or funisitis at term, although signifi cant, does not accurately differentiate between septic and non-septic patients. There is a signifi cant trend between increasing stages of HC and sepsis. Chorionic plate vasculitis is also signifi cantly associated with sepsis. Therefore, placenta histologic fi ndings of HC, funisitis, and CPV in full term infants, although signifi cant, are not specifi c and should not be used as independent markers to diagnose sepsis in order to prevent unnecessary antibiotic treatment.
Progression of a Mixed Epithelial Stromal Tumor Harboring DICER1
Mutations KA La Fortune, DA Hill, HP Cathro, RD LeGallo. University of Virginia, Charlottesville, VA; Children's National Medical Center, Washington, DC. Background: Germline inactivating DICER1 mutations predispose patients to a broad range of rare benign and malignant neoplasms, most notably pleuropulmonary blastoma (PPB) and cystic nephroma (CN). While PPB harbors the potential to progress from a purely cystic lesion to anaplastic solid sarcoma, CN is considered benign with no malignant potential. We report a case of a multiloculated renal epithelial stromal tumor that recurred as a high-grade sarcoma harboring biallelic DICER1 mutations. Design: A 20-year-old woman presented to the emergency department with gross hematuria and fl ank pain. Renal ultrasound demonstrated a multiloculated mass arising from the left renal parenchyma most consistent with a CN. She underwent partial nephrectomy and the lesion was diagnosed as a mixed epithelial and stromal tumor. Eleven months post-resection, she returned with acute right adnexal tenderness. MRI revealed a heterogeneously enhancing soft-tissue mass of the lower pelvis that was biopsied to reveal a high-grade spindle cell sarcoma. Due to the lesion's similarities to a CN, the possibility of a DICER1 mutation was raised. Frozen tissue from the sarcomatous resection specimen was submitted for mutation analysis.
Results: Biallelic DICER1 mutations were identifi ed from tumor-derived DNA. The fi rst mutation introduced a stop codon for Arginine (Arg745X) and the second mutation introduced a missense mutation substituting lysine for glutamine (Glu1813Lys). Germline DNA was not available for analysis.
Conclusions:
The DICER1 mutations identifi ed in this sarcoma are similar to reported germline mutations and secondarily acquired mutations in patients with PPB and related tumors. While sporadic DICER1 mutations are increasingly recognized in a low percentage of malignancies including rare cases of embryonal rhabdomyosarcoma and even less frequently nephroblastoma, our case does not represent either of these categories. We report the fi rst case of a DICER1 mutation in a malignant cystic renal tumor, which raises the possibility of sarcomatous transformation of CNs similar to the biologic progression of PPB. P Lokhandwala, D Zander, N Williams, H Mani, M Walls, C Abendroth . PSHMC, Hershey, PA. Background: The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has received limited performance testing in pediatric populations. We completed a retrospective cytologic-histologic correlative analysis of all pediatric thyroid FNAs performed in the last 3.5 years at our tertiary care medical center to evaluate the ability of Bethesda System classifi cation to predict histology. Design: A search of our CoPath database from March 2010 to August 2013 yielded 32 thyroid FNAs obtained from 23 children aged 10 to 18 years. This represented 2% of all thyroid FNAs performed at our institution over this time period. The medical records were searched for subsequent surgical pathology specimens and the histologic diagnoses were compared with the FNA interpretations. Results: A tabulation of thyroid FNA interpretations and subsequent histology is shown below. Although this study is limited by the relatively small number of cases in each diagnostic category, surgical follow-up of cases interpreted as suspicious or positive for malignancy yielded a malignant neoplasm in all cases (100% sensitivity, PPV=100%). Eight patients undergoing surgery after an FNA interpretation of Nondiagnostic, Benign, AUS/FLUS, or FN/SFN received histologic diagnoses that were non-neoplastic or benign neoplasms. After fi rst FNA 17 of 32 patients were triaged to clinical follow-up only, while 3 Benign and 2 Non-Diagnostic cases were followed-up with a repeat FNA that resulted in four Benign and one suspicious for follicular neoplam.
Performance Testing of the Bethesda System for Reporting Thyroid Cytopathology in Children
Histology -NonNeoplastic
(AUS=Atypia of undetermined signifi cance, FN/SFN=Follicular neoplasm/suspicious for follicular neoplasm, SFM=Suspicious for Malignancy). Conclusions: Thyroid FNAs are uncommonly performed in children, probably because of the low incidence of thyroid malignancy in this age group. Thyroid FNA had excellent sensitivity for malignancy. Intermediate categories (AUS/FLUS) and FN/SFN) were associated with subsequent benign histology, suggesting that these categories may need different management strategies in children as compared to adults, although larger/ multicenter studies are needed to further validate this. Background: Chorioamnionitis and funisitis represent histopathological manifestations of intraamniotic infection. These diagnoses follow the identifi cation of neutrophilic infi ltration of the fetal membranes or umbilical cord, respectively. Although frozen section diagnosis of intra-amniotic infection has been suggested as a viable technique in the older literature, it has not yet been rigorously studied or validated for routine clinical use. Design: Forty-nine samples of frozen umbilical cord and placental membrane tissue were included in the study. Frozen sections of each were cut at 5 um and stained using routine frozen-section hematoxylin  eosin (HE) techniques. The remaining tissue was then formalin-fi xed and parafi n-embedded to produce permanent section slides, also stained with HE. The frozen section and permanent section slides were blinded and compared by three expert pediatric pathologists individually and then by panel consensus after a delay of several weeks. The grade and stage of neutrophilic infl ammation were recorded as per the Redline grading/staging technique. Results: Frozen sections detected infl ammation with a positive likelihood ratio of 2.89 (95%CI 1.27 -6.58) and a negative likelihood ratio of 0.16 (95%CI 0.059 -0.43) in umbilical cord sections and a positive likelihood ratio of 2.28 (95%CI 1.22 -4.27) and a negative likelihood ratio of 0.15 (95%CI 0.046 -0.47) in placental membrane sections. Goodness-of-fi t testing demonstrated a statistically signifi cant correlation between frozen and permanent sections when the full grading and staging system of Redline was used (p<0.001 for both umbilical cord and placental membrane sections). The assessment of frozen sections and permanent sections was not signifi cantly different by kappa-statistic testing (p=0.06).
Conclusions:
We have performed, to our knowledge, the fi rst rigorous study of frozen section for the early post-partum diagnosis of intraamniotic infection. We demonstrated that frozen sections of fetal membranes and umbilical cord are accurate in the estimation of the grade and stage of maternal and fetal infl ammatory responses. The rapidity by which frozen sections can be performed portends a valuable and accurate diagnostic aid in the early post-partum detection of intra-amniotic infection. Early diagnosis by frozen section may be a valuable ancillary test, perhaps aiding in better outlining early post-partum treatment regimens in births complicated by intra-amniotic infection. Background: Many infants on parenteral nutrition for intestinal failure will develop parenteral nutrition associated liver disease (PNALD). It is the most severe complication of long-term parenteral nutrition. These infants present with cholestasis, which may be followed by progressive fi brosis, eventually leading to cirrhosis. The pathophysiology of PNALD is unclear. Reports have indicated that substitution of conventional soy oil-based lipid emulsions with a product based on fi sh oil that is rich in omega-3 polyunsaturated fatty acids, Omegaven © reverses hyperbilirubinemia in these patients. More recent reports, based on biopsy specimens, have not shown an improvement
